Rheumatism and Dietetic: RHUMADIET Study (Food Practices and Beliefs) (RHUMADIET)

Cross sectional study assessing food practices and beliefs in RA, AS and DA (digital arthritis)

Study Overview

Detailed Description

To investigate in patients having rheumatoid arthritis (RA), or axial spondyloarthritis (AS) or digital osteoarthritis (DA) practices and beliefs about influence of food and diet on their rheumatic disease.

200 patients of each disease will be included in this cross-sectional non interventional study Factors associated with specific practices or specific beliefs will be determined.

Only questionnaires are used in this study.

Study Type

Observational

Enrollment (Actual)

448

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75012
        • Service de Rhumatologie - Hôpital Saint Antoine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

RA (EULAR/ACR criteria) AS (ASAS criteria ) DA (ACR criteria)

Description

Inclusion Criteria:

  • Over 18 years of age
  • Rheumatoid arthritis (RA) according to ACR/EULAR criteria or axial spondyloarthritis (AS) according to ASAS 2009 criteria or digital osteoarthritis (DA) according to ACR criteria.

Exclusion Criteria:

  • Severe upper functional or psychiatric disorders
  • Patients under guardianship or trusteeship
  • Patients unable to answer the questionnaire in French

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Rheumatoid arthritis
EULAR-ACR criteria Whatever the treatment and the disease activity
Axial spondyloarthritis
ASAS criteria for axial disease Whatever the treatment and the disease activity
digital osteoarthritis
According to ACR criteria Whatever the treatment and the disease activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of patients who follow or have followed at least one diet for their rheumatic disease among gluten-free, cow's milk, lactose-free, vegetarian, vegan, Seignalet, Mediterranean, fasting period
Time Frame: 10 minutes
Binary criterion: Diet follower Yes/No
10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
comparison between each rheumatism rheumatoid arthritis, Axial spondyloarthritis digital osteoarthritis of the prevalence of patients having followed or following one or more diets
Time Frame: 10 minutes
Proportion of diet follower patients in RA versus AS versus DA. Specific food and diet questionnaires will be used in this study.
10 minutes
For each type of food, prevalence of patients with RA considering that the food influences the rheumatic pain in each rheumatic disease
Time Frame: 10 minutes
for each type of food (meat, vegetables, fruits, grains, nuts, fish, alcohol, soda), prevalence of patients with RA considering that food influence their disease symptoms
10 minutes
For each type of food, prevalence of patients with AS considering that the food influences the rheumatic pain in each rheumatic disease
Time Frame: 10 minutes
for each type of food (meat, vegetables, fruits, grains, nuts, fish, alcohol, soda), prevalence of patients with AS considering that food influence their disease symptoms
10 minutes
For each type of food, prevalence of patients with DA considering that the food influences the rheumatic pain in each rheumatic disease
Time Frame: 10 minutes
for each type of food (meat, vegetables, fruits, grains, nuts, fish, alcohol, soda), prevalence of patients with DA considering that food influence their disease symptoms
10 minutes
Research of socio-demographic or rheumatic factors associated with dieting in RA.
Time Frame: 10 minutes

In RA population:Unajusted and adjusted risk of diet (odds ratio) assiociated with the following factors reported from patient file or patient questionnaires.

  • Sociodemorgraphic parameters:Age, gender, education level.
  • Physiologic parameters: Autoantibody status, BMI
  • Clinical parameters: treatments, disease activity using DAS 28 scale.
10 minutes
Research of socio-demographic or rheumatic factors associated with dieting in AS.
Time Frame: 10 minutes

In AS population: Unajusted and adjusted risk of diet (odds ratio) assiociated with the following factors reported from patient file or patient questionnaires.

  • Sociodemorgraphic parameters:Age, gender, education level.
  • Physiologic parameters: BMI
  • Clinical parameters: treatments, disease activity using BASDAI Scale
10 minutes
Research of socio-demographic or rheumatic factors associated with dieting in DA.
Time Frame: 10 minutes

In DA population: Unajusted and adjusted risk of diet (odds ratio) assiociated with the following factors reported from patient file or patient questionnaires.

  • Sociodemorgraphic parameters: Age, gender, education level.
  • Physiologic parameters: BMI
  • Clinical parameters: treatments, disease activity using 0-100mm visual analogic scale
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jérémie SELLAM, Prof,MD, PhD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2019

Primary Completion (Actual)

April 18, 2019

Study Completion (Actual)

April 18, 2019

Study Registration Dates

First Submitted

July 9, 2018

First Submitted That Met QC Criteria

December 6, 2018

First Posted (Actual)

December 10, 2018

Study Record Updates

Last Update Posted (Actual)

August 3, 2021

Last Update Submitted That Met QC Criteria

July 31, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

3
Subscribe